支气管-瓦克索姆 (OM-85) 对慢性阻塞性肺病 (COPD) 恶化的频率的影响
Joon Young Choi1, Yong Bum Park2, Tai Joon An3
1Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
BMC pulmonary medicine
|October 7, 2023
概括
在慢性阻塞性肺病 (COPD) 患者中使用支气管-瓦克索姆 (BV) 与较少的中度和中度至重度恶化有关. 此外,BV还延迟了中度慢性肺炎恶化症状的出现,显示了其临床疗效.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性阻塞性肺病 (COPD) 恶化是一个重大的临床挑战.
- 作为一种免疫调节剂的 Broncho-Vaxom (BV) 已显示出通过平衡免疫反应来治疗 COPD 的潜力.
- 以前的研究表明,BV可能在COPD管理中提供好处.
研究的目的:
- 评估Broncho-Vaxom (BV) 在降低COPD恶化风险方面的临床疗效.
- 评估BV对COPD恶化的频率和严重性的影响.
- 为了确定VV是否可以延迟COPD恶化的发生.
主要方法:
- 韩国国家健康保险数据库 (2016-2019) 的回顾性分析.
- 在2017-2018年期间,包括238名在BV开始治疗的患者.
- 在BV开始之前收集基线数据,包括人口统计,并发性疾病,吸入器使用和恶化病史.
主要成果:
- BV使用与中度恶化 (OR=0.59) 和中度至重度恶化 (OR=0.571) 的显著减少有关.
- 中度和中度至重度恶化的发生率随着BV使用而下降 (IRR=0.75和IRR=0.77,分别).
- BV显著延迟了中度慢性肺炎恶化 (HR=0.68) 的开始.
结论:
- 支气管-瓦克索姆 (BV) 证明了临床有效性,可以减少中度和中度至重度COPD恶化的频率.
- BV治疗与中度COPD恶化发生的延迟有关.
- 这些发现支持使用BV作为治疗方案来管理COPD恶化.
相关概念视频
01:26COPD: Management Using Bronchodilators and Corticosteroids
224
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
224
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.6K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.6K
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
01:24Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
01:30Asthma-IV: Nursing Management
3.1K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.1K